| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | May 02, 2024 | Sale | $12.83 | 3,499 | 44,878 | 68,333 | May 02, 2024, 06:01 PM | |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Apr 30, 2024 | Sale | $12.04 | 1,387 | 16,703 | 71,832 | Apr 30, 2024, 06:33 PM | |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Feb 16, 2024 | Sale | $10.02 | 6,812 | 68,223 | 68,333 | Feb 16, 2024, 07:20 PM | |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Jan 30, 2024 | Sale | $7.99 | 1,671 | 13,352 | 75,145 | Jan 30, 2024, 06:53 PM | |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Dec 20, 2023 | Sale | $10.00 | 3,541 | 35,421 | 71,930 | Dec 21, 2023, 05:19 PM | |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Dec 19, 2023 | Sale | $10.00 | 10,906 | 109,093 | 75,471 | Dec 20, 2023, 04:55 PM | |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Oct 31, 2023 | Sale | $5.20 | 1,080 | 5,613 | 86,377 | Nov 01, 2023, 04:41 PM | |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Jul 31, 2023 | Sale | $9.65 | 1,245 | 12,020 | 82,571 | Aug 01, 2023, 04:28 PM | |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | May 01, 2023 | Sale | $9.88 | 721 | 7,121 | 78,930 | May 02, 2023, 04:33 PM | |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Jan 30, 2023 | Sale | $11.78 | 924 | 10,884 | 76,765 | Feb 01, 2023, 04:17 PM | |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Oct 31, 2022 | Sale | $12.88 | 739 | 9,519 | 74,803 | Nov 01, 2022, 07:35 PM | |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Aug 01, 2022 | Sale | $15.67 | 752 | 11,784 | 72,656 | Aug 02, 2022, 05:46 PM | |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | May 31, 2022 | Option Exercise | $0.84 | 68,333 | 57,400 | 70,522 | Jun 01, 2022, 04:57 PM | |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | May 02, 2022 | Sale | $11.75 | 697 | 8,190 | 2,189 | May 03, 2022, 07:03 PM | |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Feb 24, 2021 | Option Exercise | $1.76 | 35,419 | 62,297 | 35,419 | Feb 25, 2021, 04:18 PM | |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Feb 24, 2021 | Sale | $39.90 | 35,419 | 1,413,218 | 0 | Feb 25, 2021, 04:18 PM | |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Feb 22, 2021 | Option Exercise | $1.10 | 5,330 | 5,886 | 5,330 | Feb 23, 2021, 06:04 PM | |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Feb 22, 2021 | Sale | $39.93 | 5,330 | 212,839 | 0 | Feb 23, 2021, 06:04 PM | |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Feb 18, 2021 | Sale | $35.46 | 13,583 | 481,621 | 10,443 | Feb 22, 2021, 04:09 PM | |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Feb 18, 2021 | Option Exercise | $0.84 | 13,583 | 11,410 | 13,583 | Feb 22, 2021, 04:09 PM |
Menu